Arkea Bio
Latest round
- Series A
Last raised
- Sep 2026
Total raised
- $61M
Investors
- 7
About Arkea Bio
Founded in 2022 and based in Massachusetts, US, Arkea Bio Corp. operates as a research and development company in the fields of climate change, greenhouse gases, greenhouse gas reduction, greenhouse gas mitigation, and the prevention and inhibition of methane and greenhouse gas production. As of 2022, Colin South is the CEO of the company. In September 2026, Arkea Bio Corp. The company uses vaccination technology to develop solutions to minimise on-farm methane emissions, which contribute to global GHG emissions. The firm's technology can be linked into proven delivery systems and farming techniques to safely reduce global methane emissions from a wide range of different species across geographies and agronomic systems.
Who invested in Arkea Bio
7 investors across 4 rounds
See all investors in Arkea Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Arkea Bio
Who invested in Arkea Bio?
Arkea Bio has 7 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Arkea Bio raised?
Arkea Bio has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Arkea Bio last raise money?
Arkea Bio's most recent round on record is a Series A, in Sep 2026.
What does Arkea Bio do?
Founded in 2022 and based in Massachusetts, US, Arkea Bio Corp.
Where is Arkea Bio headquartered?
Arkea Bio is headquartered in Charlestown, US.
Which VCs invest in companies like Arkea Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Arkea Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Arkea Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.